Health plans in 2025 will pay more attention to cybersecurity. While the majority of hacks and breaches target healthcare ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

In 2024, UnitedHealth Group saw full year revenue grow 8% over 2023 to reach $400.3 billion. Adjusted earnings from ...

The healthcare industry can’t afford to be stagnant. Cost pressures, operational pressures and real human lives are at stake ...

Most infants born before December were administered nirsevimab, while those whose mothers reached eligible gestational age ...